Clinical Trial Update: Multiple Ascending Dose Study of AMG 598 in Adults With Obesity [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of AMG 598 in adults with obesity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AMG 598

Snippet

Sponsor: Amgen | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2023-09-14